Zeng-Feng Wang

1.9k total citations
17 papers, 1.2k citations indexed

About

Zeng-Feng Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Zeng-Feng Wang has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Gastroenterology. Recurrent topics in Zeng-Feng Wang's work include Sarcoma Diagnosis and Treatment (7 papers), Gastrointestinal Tumor Research and Treatment (6 papers) and Vascular Tumors and Angiosarcomas (4 papers). Zeng-Feng Wang is often cited by papers focused on Sarcoma Diagnosis and Treatment (7 papers), Gastrointestinal Tumor Research and Treatment (6 papers) and Vascular Tumors and Angiosarcomas (4 papers). Zeng-Feng Wang collaborates with scholars based in United States, Poland and Finland. Zeng-Feng Wang's co-authors include Markku Miettinen, Jerzy Lasota, Maarit Sarlomo‐Rikala, Czesław Osuch, Piotr Rutkowski, Anders Paetau, Albert Dobi, Shyh‐Han Tan, Isabell A. Sesterhenn and Shiv Srivastava and has published in prestigious journals such as The American Journal of Surgical Pathology, Modern Pathology and Archives of Pathology & Laboratory Medicine.

In The Last Decade

Zeng-Feng Wang

17 papers receiving 1.2k citations

Peers

Zeng-Feng Wang

PRM

GASTR

SURGE

ONCOL

RHEUM

Gina Z. D’Amato United States

Claudia Valverde Spain

Tomonari Takahira Japan

Milena Urbini Italy

Pierre‐Paul Bringuier France

Marcia L. Lux United States

Anne‐Valérie Decouvelaere France

Arin Schroeder United States

Umio Yamaguchi Japan

Darrel P. Cohen United States

Gina Z. D’Amato United States

Zeng-Feng Wang

1.0k ×1.5

PRM

538 ×1.0

GASTR

280 ×0.7

SURGE

447 ×1.3

ONCOL

148 ×0.6

RHEUM

Citations per year, relative to Zeng-Feng Wang Zeng-Feng Wang (= 1×) peers Gina Z. D’Amato

Countries citing papers authored by Zeng-Feng Wang

Since Specialization

Citations

This map shows the geographic impact of Zeng-Feng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeng-Feng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeng-Feng Wang more than expected).

Fields of papers citing papers by Zeng-Feng Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeng-Feng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeng-Feng Wang. The network helps show where Zeng-Feng Wang may publish in the future.

Co-authorship network of co-authors of Zeng-Feng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zeng-Feng Wang. A scholar is included among the top collaborators of Zeng-Feng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeng-Feng Wang. Zeng-Feng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Lasota, Jerzy, Artur Kowalik, Anna Felisiak-Gołąbek, et al.. (2017). SP174, NRAS Q61R Mutant-Specific Antibody, Cross-Reacts With KRAS Q61R Mutant Protein in Colorectal Carcinoma. Archives of Pathology & Laboratory Medicine. 141(4). 564–568. 8 indexed citations

Felisiak-Gołąbek, Anna, Shingo Inaguma, Artur Kowalik, et al.. (2017). SP174 Antibody Lacks Specificity for NRAS Q61R and Cross-Reacts With HRAS and KRAS Q61R Mutant Proteins in Malignant Melanoma. Applied immunohistochemistry & molecular morphology. 26(1). 40–45. 15 indexed citations

Lasota, Jerzy, et al.. (2017). New Mechanisms of mTOR Pathway Activation in KIT-mutant Malignant GISTs. Applied immunohistochemistry & molecular morphology. 27(1). 54–58. 5 indexed citations

Lasota, Jerzy, Anna Felisiak-Gołąbek, Bartosz Wasąg, et al.. (2016). Frequency and clinicopathologic profile of PIK3CA mutant GISTs: molecular genetic study of 529 cases. Modern Pathology. 29(3). 275–282. 35 indexed citations

Kopczyński, Janusz, Artur Kowalik, Małgorzata Chłopek, et al.. (2015). Oncogenic Activation of the Wnt/β-Catenin Signaling Pathway in Signet Ring Stromal Cell Tumor of the Ovary. Applied immunohistochemistry & molecular morphology. 24(5). e28–e33. 19 indexed citations

Lasota, Jerzy, et al.. (2014). Nuclear expression and gain-of-function β-catenin mutation in glomangiopericytoma (sinonasal-type hemangiopericytoma): insight into pathogenesis and a diagnostic marker. Modern Pathology. 28(5). 715–720. 61 indexed citations

Alimchandani, Meghna, Zeng-Feng Wang, & Markku Miettinen. (2014). CD30 Expression in Malignant Vascular Tumors and Its Diagnostic and Clinical Implications. Applied immunohistochemistry & molecular morphology. 22(5). 358–362. 13 indexed citations

Lasota, Jerzy, Artur Kowalik, Bartosz Wasąg, et al.. (2014). Detection of the BRAF V600E Mutation in Colon Carcinoma. The American Journal of Surgical Pathology. 38(9). 1235–1241. 45 indexed citations

Laskin, William B., Jerzy Lasota, John F. Fetsch, et al.. (2014). Intranodal Palisaded Myofibroblastoma. The American Journal of Surgical Pathology. 39(2). 197–205. 19 indexed citations

10.

Lasota, Jerzy, Liqiang Xi, Moses O. Evbuomwan, et al.. (2013). No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases. Modern Pathology. 26(11). 1488–1491. 23 indexed citations

11.

Miettinen, Markku, et al.. (2012). Vascular Endothelial Growth Factor Receptor 2 as a Marker for Malignant Vascular Tumors and Mesothelioma. The American Journal of Surgical Pathology. 36(4). 629–639. 87 indexed citations

12.

Miettinen, Markku, Maarit Sarlomo‐Rikala, & Zeng-Feng Wang. (2011). Claudin-5 as an Immunohistochemical Marker for Angiosarcoma and Hemangioendotheliomas. The American Journal of Surgical Pathology. 35(12). 1848–1856. 24 indexed citations

13.

Miettinen, Markku & Zeng-Feng Wang. (2011). Prox1 Transcription Factor as a Marker for Vascular Tumors—Evaluation of 314 Vascular Endothelial and 1086 Nonvascular Tumors. The American Journal of Surgical Pathology. 36(3). 351–359. 51 indexed citations

14.

Miettinen, Markku, Zeng-Feng Wang, Anders Paetau, et al.. (2011). ERG Transcription Factor as an Immunohistochemical Marker for Vascular Endothelial Tumors and Prostatic Carcinoma. The American Journal of Surgical Pathology. 35(3). 432–441. 243 indexed citations

15.

Miettinen, Markku, Zeng-Feng Wang, Maarit Sarlomo‐Rikala, et al.. (2011). Succinate Dehydrogenase-Deficient GISTs. The American Journal of Surgical Pathology. 35(11). 1712–1721. 246 indexed citations

16.

Miettinen, Markku, Zeng-Feng Wang, & Jerzy Lasota. (2009). DOG1 Antibody in the Differential Diagnosis of Gastrointestinal Stromal Tumors. The American Journal of Surgical Pathology. 33(9). 1401–1408. 294 indexed citations

17.

Lasota, Jerzy, Zeng-Feng Wang, Leslie H. Sobin, & Markku Miettinen. (2009). Gain-of-function PDGFRA mutations, earlier reported in gastrointestinal stromal tumors, are common in small intestinal inflammatory fibroid polyps. A study of 60 cases. Modern Pathology. 22(8). 1049–1056. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact